A double-blind randomized clinical trial of Brazilian red propolis dentifrice efficacy in orthodontic patients
-
- Lotif Mara Assef L.
- Pharmacy, Dentistry and Nursing College, Federal University of Ceará
-
- Valadas Lídia Audrey R.
- Pharmacy, Dentistry and Nursing College, Federal University of Ceará Department of Preventive and Community Dentistry, University of Buenos Aires
-
- Fechine Francisco Vagnaldo
- Clinical Pharmacology Unit, Drug Research and Development Center, Federal University of Ceará
-
- Fonseca Said G. C.
- Pharmacy, Dentistry and Nursing College, Federal University of Ceará
-
- Bandeira Mary Anne M.
- Pharmacy, Dentistry and Nursing College, Federal University of Ceará
-
- Dantas Thereza Cristina F. B.
- Paulo Picanço College of Dentistry University Center Christus
-
- Rodrigues Neto Edilson M.
- Pharmacy, Dentistry and Nursing College, Federal University of Ceará
-
- Squassi Aldo
- Department of Preventive and Community Dentistry, University of Buenos Aires
-
- Fonteles Marta Maria F.
- Pharmacy, Dentistry and Nursing College, Federal University of Ceará
この論文をさがす
抄録
<p>Purpose: The objective was to evaluate the efficacy of a dentifrice containing Brazilian Red Propolis (BRP) against salivary Lactobacillus spp. and plaque formation.</p><p>Methods: This was a randomized, double-blind clinical trial. Forty-two participants were randomized into two groups according to the dentifrice employed: G1 (fluoridated BRP dentifrice) and G2 (fluoridated common dentifrice). Saliva was collected and the visible plaque index (VPI) was recorded at the baseline (D0) and 4 weeks after day 0 (D28). Microbiological analysis was performed using two dilutions. Lactobacillus spp. isolates were identified and their abundance was expressed as log (CFU/mL).</p><p>Results: For the first dilution, the counts of Lactobacillus spp. in G1 was 1.15 ± 0.41 at D0 and 0.68 ± 0.15 at D28 (P < 0.05) and in G2 it was 1.33 ± 0.52 at D0 and 1.84 ± 0.39 at D28 (P < 0.05). For the second dilution, the corresponding values in G1 and G2 were 0.87 ± 0.34 and 0.64 ± 0.37, respectively (P = 0.1547), and 1.54 ± 0.47 and 1.62 ± 0.37, respectively (P = 0.9999). The corresponding VPI values for G1 and G2 were 38.10 ± 17.95 and 20.60 ± 16.44, respectively (P < 0.05), and 38.38 ± 19.65 and 27.40 ± 14.63, respectively (P = 0.03).</p><p>Conclusion: The dentifrice containing BRP showed antimicrobial activity against Lactobacillus spp. and decreased the VPI for up to 4 weeks.</p>
収録刊行物
-
- Ｊｏｕｒｎａｌ ｏｆ Ｏｒａｌ Ｓｃｉｅｎｃｅ
-
Ｊｏｕｒｎａｌ ｏｆ Ｏｒａｌ Ｓｃｉｅｎｃｅ 64 (1), 28-32, 2022
日本大学歯学部